Skip to content

Clinical trials

Recruiting Fabry Disease trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fabry Disease Status: Recruiting Country / region: Italy Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20181
20221
20231
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
IRCCS Azienda Ospedaliero-Universitaria di Bologna3
Chiesi Farmaceutici S.p.A.1
Chiesi Italia1
Genzyme, a Sanofi Company1
IRCCS Policlinico S. Donato1
Scientific Institute San Raffaele1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fabry Disease8
Cardiomyopathy, Hypertrophic3
Amyloid Neuropathies, Familial2
Cardiomyopathy, Dilated2
Death, Sudden, Cardiac2
Angiokeratoma1
Arrhythmogenic Right Ventricular Dysplasia1
Cardiomyopathies1
Cardiomyopathy, Restrictive1
Glycogen Storage Disease1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.